USPTO serial 79322943
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
CHRISTINA M. LICURSI
Christina M. Licursi Wolf, Greenfield & Sacks, P.C.600 Atlantic AvenueBoston, MA 02210UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Apparatus and instruments for microscopy, namely, super-resolution microscopes; apparatus and instruments for biological sample characterisation, including protein localisation, concentration, size of molecule and sample variability for scientific laboratory purposes, namely, scientific instruments in the nature of electronic analyzers for analyzing biological substances for the presence and quantity of biologics; laboratory instrument for the detection of pathogens and toxins in a biological samples for research use; apparatus and instruments for laboratory use including, measuring, detecting, monitoring and controlling devices, namely, bioreactors for laboratory use; downloadable computer software for data analysis; downloadable bioinformatics software for data analysis; scientific apparatus and instruments for biological analysis, namely, acidity analysers; diagnostic apparatus for scientific use, namely, for the detection of pathogens, biomarkers, peptides, RNA, DNA, and toxins in a biological sample for laboratory or research use; devices for biological experimentation, namely, microfluidic devices and microfluidic equipment in the nature of microfluidic manifolds, microfluidic chips and microfluidic cartridges, all for laboratory or research use in the life science field; devices for the analysis and detection of pathogens, namely, diagnostic apparatus and equipment for detecting pathogens in biological samples for laboratory or research use; devices for the analysis and detection of chemicals, namely, diagnostic apparatus for the detection of pathogens, biomarkers, peptides, RNA, DNA, and toxins in a biological sample for laboratory or research use; temperature measuring apparatus for scientific use, namely, thermometers for scientific use; temperature sensors for scientific use; apparatus for analysing substances in liquids other than for medical use, namely, flow cytometers providing cell and particle counting for laboratory use; fluid flow meters; fluid sampling apparatus other than for medical use, namely, fluid sampling kits consisting primarily of microfluidic manifolds, microfluidic chips, microfluidic cartridges, reagent containing cartridges and microfluidic compatible pumps for testing fluids; microfluidic components and devices featuring cartridges and microfluidic compatible pumps, to be used for the development, testing, research and analysis of pharmaceutical products, for chemical research and analysis, for testing, research and analysis of biological substances and for screening and characterization of nucleic acid, all being laboratory equipment and devices not used for medical purposes; glassware for scientific experiments in laboratories; test tubes and power connectors being apparatus of scientific laboratory apparatus; instruments for scientific use in the preparation of liquids containing cells, namely, flow cytometers providing cell and particle counting for laboratory use; laboratory apparatus for the dilution of liquids other than for medical use, namely, microfluidic manifolds, microfluidic chips and microfluidic cartridges, all for laboratory or research use in the scientific field; laboratory apparatus for the dispensing of liquids other than for medical use, namely, microfluidic manifolds, microfluidic chips and microfluidic cartridges, all for laboratory or research use in the scientific field; laboratory apparatus for the incubation of liquids other than for medical use, namely, microfluidic manifolds, microfluidic chips and microfluidic cartridges, all for laboratory or research use in the scientific field; laboratory apparatus for the mixing of liquids other than for medical use, namely, microfluidic manifolds, microfluidic chips and microfluidic cartridges, all for laboratory or research use in the scientific field; laboratory apparatus for the transfer of liquids other than for medical use, namely, microfluidic manifolds, microfluidic chips and microfluidic cartridges, all for laboratory or research use in the scientific field; laboratory instruments other than for medical use, namely, microfluidic manifolds, microfluidic chips and microfluidic cartridges, all for laboratory or research use in the scientific field; laboratory apparatus in the nature of controlled volume pumps for the extraction of gases; laboratory apparatus in the nature of controlled volume pumps for the extraction of liquids; control valves for regulating the flow of gases and liquids; electromagnetic solenoids in the nature of solenoid valves; solenoid valves; microchips, DNA chips; measuring laboratory apparatuses in the nature of controlled volume pumps for the extraction of gases or liquid; connecting devices for data collection, namely, optical fiber connectors; structural parts and fittings for all the aforesaid goods | ACTIVE | — |
| 010 | Medical, scientific and veterinary apparatus and instruments, namely, analysers for bacterial identification for medical purposes, flow cytometers and flow-based analyzers providing cell and partial analysis for medical diagnostic uses; medical and veterinary apparatus and instruments for measuring and analysing samples from humans and animals, namely, medical instruments for analysing cells, tissue, and fluids; medical apparatus and instruments for analyzing biological samples for their characterisation, including protein localisation, concentration, size of molecule and sample variability for diagnosing medical diseases and disorders; apparatus for taking and storing blood and other human and veterinary samples, namely, blood collection needles; medical specimen collection devices in the nature of glass vials and ampoules for blood and other medical and veterinary samples; medical devices and instruments for measuring, analysing, controlling and regulating fluids and gases, namely, cell culture chambers; medical devices and instruments for measuring, analysing, controlling and regulating fluids and gases, namely, medical diagnostic apparatus for the detection of cancer and tissue-based diseases, featuring testing of biological tissues, cytology, and cell-based technology; cell culture chambers for medical purposes; microfluidic devices for medical use, namely, medical apparatus for diagnostic testing in the fields of cancer and related tissue-based diseases featuring cytology and cell-based testing technology; medical devices being components and devices with microfluidic capabilities for carrying out analytical processes, medical diagnostic functions, medical research and analysis, namely, medical diagnostic apparatus for testing cancer cells and DNA; portable pump installations for medical use consisting primarily of infusion pumps and medical ventilator tubing connectors for liquids; infusion pumps for medical use in the extraction of liquids; measuring devices for medical use, namely, wearable monitors used to measure biometric data for medical use; medical instruments for analysing cells, tissue, and fluids, namely, cell culture chambers; medical instruments for analysing cells, tissue, and fluids, namely, cell culture chambers for testing cancer cells and DNA for use in the fields of cancer and other tissue-based diagnostic testing diseases, cytology and cell-based testing diseases, all featuring the analysis of liquid substances; medical instruments for analysing cells, tissue, and fluids, namely, cell culture chambers; drug delivery devices sold empty, namely, syringes for medical purposes; apparatus for analysing substances in liquids for medical use, namely, medical instruments for analysing cells, tissue, and fluids in the nature of cell culture chambers and medical diagnostic apparatus featuring fluid processing and manipulation, for testing cancer cells and DNA for use in the fields of cancer and other tissue-based diseases, cytology and cell-based diseases; medical and veterinary apparatus and instruments for microfluidic applications, namely, spectrofluorometers; medical devices and instruments for flow diagnosis, namely, spectrofluorometers; diagnostic instruments for medical use in the form of microsensors and spectrofluorometers featuring microfluidic devices, microfluidic systems and micro-networks; structural parts and fittings for all the aforesaid goods | ACTIVE | — |
| 037 | Machinery installation; machinery installation, maintenance and repair; machinery repair; maintenance and repair of scientific equipment; maintenance and repair of fluid flow meters and fluid sampling apparatus; maintenance and repair of medical instruments, apparatus and equipment; maintenance of data communication networks; maintenance of data processing apparatus; maintenance of data-processing terminals; rental of tools for scientific research and use; consultancy relating to all the aforesaid services | ACTIVE | — |
| 042 | Scientific laboratory services featuring the measuring, analysing, detecting, monitoring of biological samples; scientific laboratory services for the analysis and detection of pathogens; scientific laboratory services for the analysis and detection of chemicals, scientific and laboratory services for analysing substances in liquids other than for medical use; custom design and engineering of laboratory apparatus for the dilution of liquids other than for medical use; product design and development of scientific components and devices with microfluidic capabilities; consultancy relating to all the aforesaid services | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| May 13, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 24, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 23, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 23, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 23, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 23, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 7, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 7, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 6, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 20, 2023 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Oct 20, 2023 | EXDM | EXPARTE APPEAL DISMISSED AS MOOT | — |
| Oct 18, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 18, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Oct 18, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 2, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 2, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 2, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 2, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 2, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 19, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 10, 2023 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Aug 10, 2023 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Aug 10, 2023 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Aug 10, 2023 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Aug 10, 2023 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Apr 5, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 15, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 15, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Feb 12, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Feb 12, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 12, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 8, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 7, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 7, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 9, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 9, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 9, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 19, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 19, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 19, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 11, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 1, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 27, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Dec 27, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 27, 2021 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Dec 27, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 27, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 27, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Dec 15, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 15, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 17, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 16, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 7, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 19, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 15, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 14, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |